Posts by cstephenson@legacymedsearch.com
Northwestern Memorial Hospital Performs First US Robotic Lung Volume Reduction Surgery
Northwestern Memorial Hospital is the first in the country to successfully complete robotic-assisted lung volume reduction surgery (LVRS) using the da Vinci Xi Surgical System® to remove diseased, emphysematous tissue within the lungs for the treatment of severe emphysema, a progressive form of chronic obstructive pulmonary disease (COPD). The robotic procedure allows the surgeon to precisely remove the…
Read More1 in 3 GoFundMe Campaigns are for Medical Bills and That’s a Problem Says GoFundMe CEO
Scrolling through the GoFundMe website reveals seemingly an endless number of people who need help or community support. A common theme: the cost of health care. It didn’t start out this way. Back in 2010, when the crowdfunding website began, it suggested fundraisers for “ideas and dreams,” “wedding donations and honeymoon registry” or “special occasions.”…
Read MoreTransEnterix Wins FDA Clearance for Senhance Ultrasonic Instruments
TransEnterix, Inc., a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the Company received FDA 510(k) clearance for its Senhance Ultrasonic System. “Advanced energy devices are used within a high percentage of cases across a wide range of procedures, which make them a critical tool for…
Read MoreOSSIO Receives 501(k) Clearance for Bio-Integrative Bone Pins
The FDA has granted 510(k) clearance to Ossio for its family of bio-integrative bone pins, which secure broken bones during the healing process while leaving no permanent hardware behind. The pins are made of a natural mineral fiber matrix that aims to replace the more permanent, metal fixation implants used in fractures, bone cuttings or…
Read MoreIRRAS’s Intracranial Bleeding Management Device Used on First U.S. Patient
IRRAS AB, a commercial-stage medical-technology company, today announced that the first patient in the United States was successfully treated with IRRAflow, the company’s initial product that offers an innovative, therapeutic approach to the fluid management of patients with intracranial bleeding. “The US is the largest market for intracranial procedures, and we are making significant progress engaging neurocritical care centers and specialty hospitals across the country,” said Kleanthis G. Xanthopoulos, Ph.D.,…
Read MorePaula’s Predictions for the 2019 MedTech Job Market
THE GLOBAL CANDIDATE-CENTRIC JOB MARKET WILL TURN IN 2019 Paula’s Predictions for the 2019 MedTech Job Market (What candidates and companies should do NOW) THE BAD NEWS If you’ve watched the news in December (or your stock portfolio valuation,) you’ll note that there is a shift in the winds and increased anxiety amongst financial pundits,…
Read MoreFDA Grants De Novo Authorization to Pressure Ulcer Risk Assessment Device
Bruin Biometrics, LLC has been granted U.S. Food and Drug Administration marketing authorization for the SEM Scanner, a wireless handheld device that is indicated for use as an adjunct to the standard of care when assessing patients who are at increased risk for pressure ulcers. The SEM Scanner is the world’s first FDA-authorized device to…
Read MoreTitan Medical’s Sport Robotic System Nearing Commercialization
Titan Medical Inc., a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery, announces that it has completed the system engineering confidence build for all components of its single-port robotic surgery system. This accomplishment highlights the completion of a new camera system along with the…
Read MoreTeva’s Digital Inhaler Now FDA Cleared
Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently received marketing approval from the US FDA, according to a release from the company. The device will first become available next year through a “small number” of healthcare system pilot partnerships, with a full national launch currently planned for 2020. Teva’s ProAir Digihaler is indicated for…
Read MoreBrainScope Receives FDA Clearance for Multi-Parameter Concussion Assessment
BrainScope, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it has received FDA clearance to include additional language in its product’s Indications for Use (IFU), adding key terminology related to “multi-modal, multi-parameter assessment” of “concussion” and “mild Traumatic Brain Injury”, as well as an expanded and…
Read More